483
Agora EdgeFDA 483 - Agora Edge - December 14, 2022
Discuss this record with AI
Record Details
An FDA inspection of Agora Edge, a contract manufacturer in Saint Petersburg, FL, revealed a significant deficiency in their quality system. The firm failed to adequately establish procedures for the acceptance of raw materials from suppliers. This indicates a moderate concern regarding the control of incoming materials used in manufacturing.
Open in Dashboard
ID · 15466036-37a2-4dda-bd38-1ac5c00ad6d2